1. Home
  2. TCRX vs SOTK Comparison

TCRX vs SOTK Comparison

Compare TCRX & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • SOTK
  • Stock Information
  • Founded
  • TCRX 2018
  • SOTK 1975
  • Country
  • TCRX United States
  • SOTK United States
  • Employees
  • TCRX N/A
  • SOTK N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • TCRX Health Care
  • SOTK Technology
  • Exchange
  • TCRX Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • TCRX 64.1M
  • SOTK 52.1M
  • IPO Year
  • TCRX 2021
  • SOTK 1987
  • Fundamental
  • Price
  • TCRX $0.98
  • SOTK $3.90
  • Analyst Decision
  • TCRX Strong Buy
  • SOTK Hold
  • Analyst Count
  • TCRX 7
  • SOTK 1
  • Target Price
  • TCRX $8.50
  • SOTK N/A
  • AVG Volume (30 Days)
  • TCRX 1.1M
  • SOTK 28.6K
  • Earning Date
  • TCRX 11-12-2025
  • SOTK 10-14-2025
  • Dividend Yield
  • TCRX N/A
  • SOTK N/A
  • EPS Growth
  • TCRX N/A
  • SOTK 6.63
  • EPS
  • TCRX N/A
  • SOTK 0.10
  • Revenue
  • TCRX $8,423,000.00
  • SOTK $20,607,030.00
  • Revenue This Year
  • TCRX $255.18
  • SOTK $2.67
  • Revenue Next Year
  • TCRX N/A
  • SOTK $8.20
  • P/E Ratio
  • TCRX N/A
  • SOTK $41.99
  • Revenue Growth
  • TCRX N/A
  • SOTK N/A
  • 52 Week Low
  • TCRX $0.96
  • SOTK $3.23
  • 52 Week High
  • TCRX $4.94
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 28.55
  • SOTK 35.74
  • Support Level
  • TCRX $0.96
  • SOTK $4.30
  • Resistance Level
  • TCRX $1.25
  • SOTK $4.53
  • Average True Range (ATR)
  • TCRX 0.13
  • SOTK 0.22
  • MACD
  • TCRX -0.02
  • SOTK -0.08
  • Stochastic Oscillator
  • TCRX 4.00
  • SOTK 9.66

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: